Thank you very much, Madam Chair.
There are so many questions I'd like to ask.
I've been hearing from you today about the importance of the plan and an integrated international plan that does include research. It does include discovery, and it will ultimately include manufacturing facilities if they're required, as far as capacity around the world, and I understand that was the big reason for cancelling the manufacturing facility.
I'd like to start with Dr. Bertozzi, because I get from your comments that you understand the disappointment, and I respect very much the fact that you have a global HIV perspective, great partnerships, a coordinated effort, and the reality is that resources need to be focused on the best uses and the most up-to-date priorities in a fast-changing global environment.
I am wondering if you could speak to the current status of the HIV vaccine. Is Canada able to make a significant contribution without the vaccine facility?